rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1997-6-10
|
pubmed:abstractText |
The efficacy of combination therapy with 5-flucytosine and an IgG1 monoclonal antibody to Cryptococcus neoformans capsular glucuronoxylomannan was studied in vitro with J774. 16 murine macrophage-like cells and in vivo in murine cryptococcal infection. The combination of 5-flucytosine and IgG1 was more effective in reducing the numbers of C. neoformans colony-forming units in vitro and in vivo than either agent alone.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0305-7453
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
617-22
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9182119-Animals,
pubmed-meshheading:9182119-Antibodies, Monoclonal,
pubmed-meshheading:9182119-Antifungal Agents,
pubmed-meshheading:9182119-Cryptococcosis,
pubmed-meshheading:9182119-Cryptococcus neoformans,
pubmed-meshheading:9182119-Female,
pubmed-meshheading:9182119-Flucytosine,
pubmed-meshheading:9182119-Immunoglobulin G,
pubmed-meshheading:9182119-Macrophages,
pubmed-meshheading:9182119-Mice,
pubmed-meshheading:9182119-Mice, Inbred A,
pubmed-meshheading:9182119-Microbial Sensitivity Tests,
pubmed-meshheading:9182119-Phagocytosis,
pubmed-meshheading:9182119-Polysaccharides
|
pubmed:year |
1996
|
pubmed:articleTitle |
Combination of 5-flucytosine and capsule-binding monoclonal antibody in the treatment of murine Cryptococcus neoformans infections and in vitro.
|
pubmed:affiliation |
Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|